News & Events about Accelerate Diagnostics Inc.
StockNews.com lowered shares of Accelerate Diagnostics (NASDAQ:AXDX Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning. Accelerate Diagnostics Trading Down 3.7 % Shares of NASDAQ AXDX opened at $0.70 on Wednesday. The firm has a market cap of...
Globe Newswire
2 months ago
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Accelerate Diagnostics, Inc. (NASDAQ: AXDX), and Veru Inc. (NASDAQ: VERU). Our investigations concern whether these companies have ...
Globe Newswire
2 months ago
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA), Accelerate Diagnostics, Inc. (NASDAQ: AXDX), Instil Bio, Inc. (NASDAQ: TIL), and ...
Globe Newswire
2 months ago
NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Accelerate Diagnostics, Inc. (NASDAQ: AXDX), and Instil Bio, Inc. (NASDAQ: TIL). Our investigations concern whether these companies ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX PR Newswire NEW YORK, Nov. 4, 2022 NEW YORK, Nov. 4, 2022...